GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mercury Laboratories Ltd (BOM:538964) » Definitions » Book Value per Share

Mercury Laboratories (BOM:538964) Book Value per Share : ₹0.00 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Mercury Laboratories Book Value per Share?

Mercury Laboratories's book value per share for the quarter that ended in Dec. 2024 was ₹0.00.

During the past 12 months, Mercury Laboratories's average Book Value Per Share Growth Rate was 8.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 11.30% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 12.00% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 12.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Mercury Laboratories was 16.70% per year. The lowest was 9.30% per year. And the median was 11.75% per year.

Mercury Laboratories's current price is ₹799.00. Its book value per share for the quarter that ended in Dec. 2024 was ₹0.00. Hence, today's PB Ratio of Mercury Laboratories is .

During the past 11 years, the highest P/B Ratio of Mercury Laboratories was 3.48. The lowest was 0.26. And the median was 1.99.

Good Sign:

Mercury Laboratories Ltd stock PB Ratio (=1.92) is close to 1-year low of 1.92


Mercury Laboratories Book Value per Share Historical Data

The historical data trend for Mercury Laboratories's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mercury Laboratories Book Value per Share Chart

Mercury Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 266.48 307.46 335.89 380.24 423.65

Mercury Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 423.65 - 430.80 -

Competitive Comparison of Mercury Laboratories's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Mercury Laboratories's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mercury Laboratories's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mercury Laboratories's PB Ratio distribution charts can be found below:

* The bar in red indicates where Mercury Laboratories's PB Ratio falls into.



Mercury Laboratories Book Value per Share Calculation

Mercury Laboratories's Book Value Per Share for the fiscal year that ended in Mar. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(508.4-0.0)/1.2
=423.65

Mercury Laboratories's Book Value Per Share for the quarter that ended in Dec. 2024 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(N/A-0.0)/1.2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.


Mercury Laboratories  (BOM:538964) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Mercury Laboratories Book Value per Share Related Terms

Thank you for viewing the detailed overview of Mercury Laboratories's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Mercury Laboratories Business Description

Traded in Other Exchanges
N/A
Address
Gorwa Road, 2/13-14, Gorwa Industrial estate, P.B. No. 3001, Vadodara, GJ, IND, 390016
Mercury Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and distribution of pharmaceutical drugs, herbs, and laboratory and surgical materials. The group produces medicines and formulations in the segments of pediatrics, obstetrics, gynecology, surgeon segment, multivitamin and nutrition supplements, antibiotics, and others. The company sells its products in India and internationally, of which key revenue is derived from sales made in India.

Mercury Laboratories Headlines

No Headlines